BenevolentAI (AMS: BAI)
VerifiedBenevolentAI (Euronext Amsterdam: BAI), a leader in applying advanced AI to accelerate biopharma drug discovery.
Overview
BenevolentAI (Euronext Amsterdam: BAI), a leader in applying advanced AI to accelerate biopharma drug discovery.
Pros
- Actively developed and widely used
Cons
- Feature set changes quickly
Key Features
- BenevolentAI (AMS: BAI) covers the core ai healthcare, wellness & medical use cases
- Web-based, no local install required
- Actively maintained and regularly updated
Best For
- Teams and creators working on ai healthcare, wellness & medical
- Anyone testing the space without an upfront budget
- Buyers who want a highly rated, well-established option
Pricing Model
Freemium. Free tier available, with paid plans unlocking higher limits, faster processing and advanced features.
Screenshots
Live preview of BenevolentAI (AMS: BAI)'s website.
User Reviews
4.5based on 0 reviews- No user reviews yet — be the first to rate BenevolentAI (AMS: BAI).